C.H, Chen, P.Y, Chang, U.M, Kan, L.S, Fang, W.H, Tsai, K.S, Lin, S.B. Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci. 2005, 77, 252 265. 71. Miyamoto, I, Liu, J, Shimizu, K, Sato, M, Kukita, A, Kukita, T, Kondo, R. Regulation of osteoclastogenesis by ganoderic acid DM isolated Rapamycin 53123-88-9 from Ganoderma lucidum. Eur. J. Pharmacol. 2009, 602, 1 7. 72. Tang, W, Liu, J.W, Zhao, W.M, Wei, D.Z, Zhong, J.J. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci. 2006, 80, 205 211. 73. Kim, S.M, Lee, S.Y, Cho, J.S, Son, S.M, Choi, S.S, Yun, Y.P, Yoo, H.S, Yoon do, Y, Oh, K.W, Han, S.B, Hong, J.T. Combination of ginsenoside Rg3 with docetaxel enhances the Toxins 2010, 2 2456 susceptibility of prostate cancer cells via inhibition of NF kappaB.
Eur. altretamine J. Pharmacol. 2010, 631, 1 9. 74. Liu, T.G, Huang, Y, Cui, D.D, Huang, X.B, Mao, S.H, Ji, L.L, Song, H.B, Yi, C. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 2009, 9, 250. 75. Wang, J, Qiao, L, Li, Y, Yang, G. Ginsenoside Rb1 attenuates intestinal ischemia reperfusioninduced liver injury by inhibiting NF kappaB activation. Exp. Mol. Med. 2008, 40, 686 698. 76. Zhang, Z, Li, X, Lv, W, Yang, Y, Gao, H, Yang, J, Shen, Y, Ning, G. Ginsenoside Re reduces insulin resistance through inhibition of c Jun NH2 terminal kinase and nuclear factorkappaB. Mol. Endocrinol. 2008, 22, 186 195. 77. Curtin, J.F, Liu, N, Candolfi, M, Xiong, W, Assi, H, Yagiz, K, Edwards, M.
R, Michelsen, K.S, Kroeger, K.M, Liu, C, Muhammad, A.K, Clark, M.C, Arditi, M, Comin Anduix, B, Ribas, A, Lowenstein, P.R, Castro, M.G. HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med. 2009, 6, e10. 78. Hsiang, C.Y, Lai, I.L, Chao, D.C, Ho, T.Y. Differential regulation of activator protein 1 activity by glycyrrhizin. Life Sci. 2002, 70, 1643 1656. 79. Matsui, S, Sonoda, Y, Sekiya, T, Aizu Yokota, E, Kasahara, T. Glycyrrhizin derivative inhibits eotaxin 1 production via STAT6 in human lung fibroblasts. Int. Immunopharmacol. 2006, 6, 369 375. 80. Menegazzi, M, Di Paola, R, Mazzon, E, Genovese, T, Crisafulli, C, Dal Bosco, M, Zou, Z, Suzuki, H, Cuzzocrea, S. Glycyrrhizin attenuates the development of carrageenan induced lung injury in mice.
Pharmacol. Res. 2008, 58, 22 31. 81. Niwa, K, Lian, Z, Onogi, K, Yun, W, Tang, L, Mori, H, Tamaya, T. Preventive effects of glycyrrhizin on estrogen related endometrial carcinogenesis in mice. Oncol. Rep. 2007, 17, 617 622. 82. Takei, H, Baba, Y, Hisatsune, A, Katsuki, H, Miyata, T, Yokomizo, K, Isohama, Y. Glycyrrhizin inhibits interleukin 8 production and nuclear factor kappaB activity in lung epithelial cells, but not through glucocorticoid receptors. J. Pharmacol. Sci. 2008, 106, 460 468. 83. Wang, J.Y, Guo, J.S, Li, H, Liu, S.L, Zern, M.A. Inhibitory effect of glycyrrhizin on NF kappaB binding activity in CCl4 plus ethanol induced liver cirrhosis in rats. Liver 1998, 18, 180 185. 84. Chintharlapalli, S, Papineni, S, Jutooru, I, McAlees, A, Safe, S.
Structure dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator activated receptor {gamma} agonists in colon cancer cells. Mol. Cancer Ther. 2007, 6, 1588 1598. 85. Lee, C.S, Kim, Y.J, Lee, M.S, Han, E.S, Lee, S.J. 18beta Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti cancer drug toxicity. Life Sci. 2008, 83, 481 489. 86. Satomi, Y, Nishino, H, Shibata, S. Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2. Anticancer Res. 2005, 25, 4043 4047. 87. Aktan, F, Henness, S, Roufogal